Your browser doesn't support javascript.
loading
Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses.
Jouhault, Quentin; Cherqaoui, Bilade; Jobart-Malfait, Aude; Glatigny, Simon; Lauraine, Marc; Hulot, Audrey; Morelle, Guillaume; Hagege, Benjamin; Ermoza, Kétia; El Marjou, Ahmed; Izac, Brigitte; Saintpierre, Benjamin; Letourneur, Franck; Rémy, Séverine; Anegon, Ignacio; Boissier, Marie-Christophe; Chiocchia, Gilles; Breban, Maxime; Araujo, Luiza M.
Afiliação
  • Jouhault Q; Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Montigny-le-Bretonneux, France.
  • Cherqaoui B; Laboratoire d'Excellence Inflamex, Université Paris-Centre, Paris, France.
  • Jobart-Malfait A; Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Montigny-le-Bretonneux, France.
  • Glatigny S; Laboratoire d'Excellence Inflamex, Université Paris-Centre, Paris, France.
  • Lauraine M; Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Montigny-le-Bretonneux, France.
  • Hulot A; Laboratoire d'Excellence Inflamex, Université Paris-Centre, Paris, France.
  • Morelle G; Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Montigny-le-Bretonneux, France.
  • Hagege B; Laboratoire d'Excellence Inflamex, Université Paris-Centre, Paris, France.
  • Ermoza K; Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Montigny-le-Bretonneux, France.
  • El Marjou A; Laboratoire d'Excellence Inflamex, Université Paris-Centre, Paris, France.
  • Izac B; Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Montigny-le-Bretonneux, France.
  • Saintpierre B; Laboratoire d'Excellence Inflamex, Université Paris-Centre, Paris, France.
  • Letourneur F; Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Montigny-le-Bretonneux, France.
  • Rémy S; Laboratoire d'Excellence Inflamex, Université Paris-Centre, Paris, France.
  • Anegon I; Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Montigny-le-Bretonneux, France.
  • Boissier MC; Laboratoire d'Excellence Inflamex, Université Paris-Centre, Paris, France.
  • Chiocchia G; Infection & Inflammation, UMR 1173, Inserm, UVSQ/Université Paris Saclay, Montigny-le-Bretonneux, France.
  • Breban M; Laboratoire d'Excellence Inflamex, Université Paris-Centre, Paris, France.
  • Araujo LM; Plateforme de production d'anticorps et de protéines recombinantes-Institut Curie/CNRS UMR144, Paris, France.
Front Immunol ; 13: 1072420, 2022.
Article em En | MEDLINE | ID: mdl-36818477
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espondilartrite / Interleucina-27 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espondilartrite / Interleucina-27 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article